Keywords: apt, pharma, secures, 3m, financing, pharmaceuticals, specialty
APT Pharma secures $32.3M financing
Article | 06 October 2008
APT Pharmaceuticals, a US specialty drug development company focused on inhaled treatments for serious lung diseases, has announced the completion ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
